Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study Randomized Against Placebo, Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors in Adjuvant Treatment of Breast Cancer (TRIPLE-A)

NCT03096041 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT03096041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03096041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study Randomized Against Placebo, Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors in Adjuvant Treatment of Breast Cancer (TRIPLE-A)
Lead sponsor
Centre Francois Baclesse
Phase
Not applicable
Overall status
Completed
Start date
July 5, 2017
Completion date
July 7, 2025
Enrollment
197 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, musculoskeletal pain